journal article·2022-07-22Open access

Itraconazole Nanocrystals on Hydrogel Contact Lenses via Inkjet Printing: Implications for Ophthalmic Drug Delivery

Carolin Tetyczka, Kira Brisberger, Martin Reiser, Manuel Zettl, Ramona Jeitler, Christina Winter, Dagmar Kolb, Gerd Leitinger, Martin Spoerk, Eva Roblegg

ACS Applied Nano Materials· Volume 5· Issue 7

Abstract

The therapeutic effect of common ocular drug delivery systems is often limited because tear fluid, protective biological barriers, and the blink reflex prevent drugs from reaching their target. Combining nanodrug delivery systems with contact lenses is one approach to increase the precorneal residence time and thus the drug concentration in the eye. Hence, the aim of this study was to selectively print itraconazole (ITZ) nanocrystals on commercially available 1 day soft hydrogel contact lenses using inkjet printing. For this, ITZ nanocrystals stabilized with Poloxamer 407 were prepared and optimized via wet media milling. After careful characterization, the nanocrystals were printed into vials, the printing process was adjusted, and the characteristics of the nanoformulation after printing were investigated. Finally, nanocrystals were printed onto hydrogel contact lenses. By performing a concise design of experiments (DoE), stable nanocrystals with a size of approximately 200 nm, a narrow particle size distribution, a negative surface charge, and an almost spherical shape were obtained. Compared to the bulk material, the apparent solubility was significantly increased and no changes in the solid-state behavior occurred. It was further demonstrated that inkjet printing did not affect the characteristics of the nanocrystals. Multiple layers of the ITZ nanoformulation were printed on soft hydrogel 1 day contact lenses, and a dual drug release profile was obtained in simulated tear fluid. These results clearly show that printing on contact lenses is a promising application for ophthalmic drug delivery.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Ocular Surface and Contact Lens · Advanced Drug Delivery Systems · Advancements in Transdermal Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13, 8010 Graz, Austria

Institute of Pharmaceutical Sciences, Department of Pharmaceutical Technology and Biopharmacy, University of Graz, Universitätsplatz 1, 8010 Graz, Austria

Center for Medical Research, Core Facility Ultrastructure Analysis, Medical University of Graz, Neue Stiftingtalstraße 6/II, 8010 Graz, Austria

Research Unit Electron Microscopic Techniques, Division of Cell Biology, Histology and Embryology, Gottfried Schatz Research Center for Cell Signaling, Metabolism and Aging, Medical University of Graz, Neue Stiftingtalstraße 6/II, 8010 Graz, Austria

BioTechMed-Graz, Mozartgasse 12/II, 8010 Graz, Austria

Funding

?sterreichische Forschungsf?rderungsgesellschaft

References (70)

Show source-provided references
1. 10.1124/JPET.119.25693310.1124/JPET.119.256933 ↗
2. 10.1089/JOP.2012.020010.1089/JOP.2012.0200 ↗
3. 10.3390/MOLECULES2618557710.3390/MOLECULES26185577 ↗
4. 10.1016/J.IJPHARM.2021.12109010.1016/J.IJPHARM.2021.121090 ↗
5. 10.1517/17425247.2014.88231510.1517/17425247.2014.882315 ↗
6. 10.1021/IE050793410.1021/IE0507934 ↗
7. 10.1016/S0002-9394(99)00051-310.1016/S0002-9394(99)00051-3 ↗
8. 10.1016/J.CLAE.2021.10148710.1016/J.CLAE.2021.101487 ↗
9. 10.1016/J.EJPB.2017.08.00710.1016/J.EJPB.2017.08.007 ↗
10. 10.4155/TDE.14.7510.4155/TDE.14.75 ↗
11. 10.1016/J.IJPHARM.2021.12046210.1016/J.IJPHARM.2021.120462 ↗
12. 10.1186/S43088-020-00040-410.1186/S43088-020-00040-4 ↗
13. 10.1016/J.MATTOD.2014.04.02710.1016/J.MATTOD.2014.04.027 ↗
14. 10.1016/B978-0-323-37468-2.00014-210.1016/B978-0-323-37468-2.00014-2 ↗
15. 10.1016/J.EJPB.2015.08.01210.1016/J.EJPB.2015.08.012 ↗
16. 10.1002/JPS.2367810.1002/JPS.23678 ↗
17. 10.1016/j.ijpharm.2015.10.05410.1016/j.ijpharm.2015.10.054 ↗
18. 10.3390/PHARMACEUTICS1212116810.3390/PHARMACEUTICS12121168 ↗
19. 10.1016/J.DRUDIS.2018.01.01610.1016/J.DRUDIS.2018.01.016 ↗
20. 10.1016/J.IJPHARM.2018.06.01810.1016/J.IJPHARM.2018.06.018 ↗
21. 10.3390/PHARMACEUTICS1402044910.3390/PHARMACEUTICS14020449 ↗
22. 10.1691/PH.2011.035810.1691/PH.2011.0358 ↗
23. 10.1016/J.IJBIOMAC.2020.07.30610.1016/J.IJBIOMAC.2020.07.306 ↗
24. 10.1016/J.EJPB.2016.07.00510.1016/J.EJPB.2016.07.005 ↗
25. 10.1016/J.IJPHARM.2017.03.08210.1016/J.IJPHARM.2017.03.082 ↗
26. 10.1007/S13346-016-0292-010.1007/S13346-016-0292-0 ↗
27. 10.5650/jos.ess1308210.5650/jos.ess13082 ↗
28. 10.1016/J.EXER.2015.01.02210.1016/J.EXER.2015.01.022 ↗
29. 10.3390/PHARMACEUTICS802001410.3390/PHARMACEUTICS8020014 ↗
30. 10.1016/J.IJPHARM.2012.11.04410.1016/J.IJPHARM.2012.11.044 ↗
31. 10.1016/J.HELIYON.2020.E0536510.1016/J.HELIYON.2020.E05365 ↗
32. 10.1016/j.ijpharm.2011.07.04010.1016/j.ijpharm.2011.07.040 ↗
33. 10.2478/S11534-011-0096-210.2478/S11534-011-0096-2 ↗
34. 10.3390/polym1210217210.3390/polym12102172 ↗
35. 10.1016/J.IJPHARM.2020.11968810.1016/J.IJPHARM.2020.119688 ↗
36. 10.1016/S0378-5173(02)00591-410.1016/S0378-5173(02)00591-4 ↗
37. 10.1016/J.IJPHARM.2017.04.01210.1016/J.IJPHARM.2017.04.012 ↗
38. 10.1021/ACS.MOLPHARMACEUT.6B0004610.1021/ACS.MOLPHARMACEUT.6B00046 ↗
39. 10.1016/J.EJPB.2013.12.01610.1016/J.EJPB.2013.12.016 ↗
40. 10.1016/J.IJPHARM.2015.12.02910.1016/J.IJPHARM.2015.12.029 ↗
41. 10.1016/J.XPHS.2016.04.03210.1016/J.XPHS.2016.04.032 ↗
42. 10.1016/J.IJPHARM.2017.12.02810.1016/J.IJPHARM.2017.12.028 ↗
43. 10.1021/MP500872G10.1021/MP500872G ↗
44. Sartorius Stedim Data Analytics AB · 2017
45. 10.1155/2019/687178510.1155/2019/6871785 ↗
46. 10.1038/s41598-020-80730-210.1038/s41598-020-80730-2 ↗
47. 10.1146/ANNUREV-MATSCI-070909-10450210.1146/ANNUREV-MATSCI-070909-104502 ↗
48. 10.3390/PHARMACEUTICS1001002810.3390/PHARMACEUTICS10010028 ↗
49. 10.1208/S12248-010-9183-310.1208/S12248-010-9183-3 ↗
50. 10.1016/J.AJPS.2015.01.00310.1016/J.AJPS.2015.01.003 ↗
51. 10.1021/JM070641610.1021/JM0706416 ↗
52. 10.1016/0378-5173(92)90184-410.1016/0378-5173(92)90184-4 ↗
53. 10.1007/S11095-014-1491-310.1007/S11095-014-1491-3 ↗
54. 10.3390/pharmaceutics802001610.3390/pharmaceutics8020016 ↗
55. 10.1111/j.2042-7158.2010.01022.x10.1111/j.2042-7158.2010.01022.x ↗
56. 10.1002/CEAT.20039002610.1002/CEAT.200390026 ↗
57. 10.1080/10717544.2020.185622410.1080/10717544.2020.1856224 ↗
58. 10.1016/B978-0-12-813629-4.00011-510.1016/B978-0-12-813629-4.00011-5 ↗
59. 10.1021/LA900059M10.1021/LA900059M ↗
60. 10.3390/NANO904058210.3390/NANO9040582 ↗
61. 10.1557/MRS2003.23010.1557/MRS2003.230 ↗
62. 10.3390/POLYM1212291510.3390/POLYM12122915 ↗
63. 10.1021/ACS.LANGMUIR.8B0433510.1021/ACS.LANGMUIR.8B04335 ↗
64. 10.1021/ie301403g10.1021/ie301403g ↗
65. 10.1002/PC.2470110.1002/PC.24701 ↗
66. 10.1109/EPTC.2009.541655910.1109/EPTC.2009.5416559 ↗
67. 10.1007/S00397-009-0419-Z10.1007/S00397-009-0419-Z ↗
68. 10.1016/J.IJPHARM.2014.10.00810.1016/J.IJPHARM.2014.10.008 ↗
69. 10.1016/j.xphs.2015.10.02110.1016/j.xphs.2015.10.021 ↗
70. 10.1016/J.CLAE.2020.03.01510.1016/J.CLAE.2020.03.015 ↗